Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Topical non-steroidal anti-inflammatory drugs for the treatment of cystoid macular edema post Descemet's stripping automated endothelial keratoplasty.

Japanese journal of ophthalmology·2018
Same author

Cultured Cells and ROCK Inhibitor for Bullous Keratopathy.

The New England journal of medicine·2018
Same author

Microwave treatment of the cornea leads to localised disruption of the extracellular matrix.

Scientific reports·2018
Same author

The trend of resistance to antibiotics for ocular infection of Staphylococcus aureus, coagulase-negative staphylococci, and Corynebacterium compared with 10-years previous: A retrospective observational study.

PloS one·2018
Same author

Biopsy of recurrent nasolacrimal duct obstruction using sheath-guided dacryoendoscopy.

Orbit (Amsterdam, Netherlands)·2018
Same author

The Asia Cornea Society Infectious Keratitis Study: A Prospective Multicenter Study of Infectious Keratitis in Asia.

American journal of ophthalmology·2018

Related Experiment Video

Updated: Jun 13, 2026

Corneal and Limbal Alkali Injury Induction Using a Punch-Trephine Technique in a Mouse Model
07:39

Corneal and Limbal Alkali Injury Induction Using a Punch-Trephine Technique in a Mouse Model

Published on: August 4, 2023

[Research and development for treating devastating corneal diseases].

Shigeru Kinoshita1

  • 1Department of Ophthalmology, Kyoto Prefectural University of Medicine, Japan. shigeruk@koto.kpu-m.ac.jp

Nippon Ganka Gakkai Zasshi
|April 15, 2010
PubMed
Summary
This summary is machine-generated.

Researchers are developing novel therapies for corneal diseases by investigating genetic disorders like gelatinous drop-like corneal dystrophy (GDLD) and improving ocular surface reconstruction techniques. This includes exploring treatments for Stevens-Johnson syndrome and corneal edema using regenerative medicine and advanced diagnostics.

More Related Videos

Development of a Noninvasive, Laser-Assisted Experimental Model of Corneal Endothelial Cell Loss
06:23

Development of a Noninvasive, Laser-Assisted Experimental Model of Corneal Endothelial Cell Loss

Published on: April 24, 2020

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
06:46

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies

Published on: February 15, 2019

Related Experiment Videos

Last Updated: Jun 13, 2026

Corneal and Limbal Alkali Injury Induction Using a Punch-Trephine Technique in a Mouse Model
07:39

Corneal and Limbal Alkali Injury Induction Using a Punch-Trephine Technique in a Mouse Model

Published on: August 4, 2023

Development of a Noninvasive, Laser-Assisted Experimental Model of Corneal Endothelial Cell Loss
06:23

Development of a Noninvasive, Laser-Assisted Experimental Model of Corneal Endothelial Cell Loss

Published on: April 24, 2020

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
06:46

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies

Published on: February 15, 2019

Area of Science:

  • Ophthalmology and Translational Medicine
  • Genetics and Molecular Biology
  • Regenerative Medicine

Context:

  • Corneal diseases pose significant challenges to vision, necessitating innovative therapeutic approaches.
  • Current treatments often fall short, highlighting the need for advanced research combining clinical insights with basic science.
  • Understanding the pathogenesis of specific corneal dystrophies and inflammatory conditions is crucial for developing targeted therapies.

Purpose:

  • To elucidate the underlying mechanisms of corneal diseases, including gelatinous drop-like corneal dystrophy (GDLD) and Stevens-Johnson syndrome.
  • To develop and refine advanced surgical techniques for ocular surface reconstruction, such as cultivated mucosal epithelial transplantation.
  • To explore novel therapeutic strategies for corneal edema and inflammatory ocular surface reactions, leveraging regenerative medicine and molecular targets.

Summary:

  • Investigated the pathogenesis of GDLD, linking TACSTD2 gene dysfunction to impaired corneal epithelial barriers and amyloid deposition.
  • Demonstrated the efficacy of cultivated mucosal epithelial transplantation for ocular surface reconstruction and steroid pulse therapy for Stevens-Johnson syndrome.
  • Identified EP3 and TLR3 roles in ocular surface inflammation, explored glutathione's role in ocular surface epithelium function, and developed new corneal edema treatments using regenerative medicine.
  • Developed a novel tear function test analyzing tear film lipid layer spread for improved diagnostics.

Impact:

  • Advances in understanding corneal disease pathogenesis pave the way for targeted therapeutic interventions.
  • Cultivated epithelial transplantation offers a promising solution for severe ocular surface damage and reconstruction.
  • Regenerative medicine approaches, including cultivated corneal endothelial transplantation, show potential for treating corneal edema and dysfunction.
  • Novel diagnostic tools like the tear film lipid layer analysis enhance the management of dry eye and other tear-related conditions.